You are here
Dr Dan Pellicci
Dr Pellicci completed his PhD in 2013 in the Department of Microbiology and Immunology at the University of Melbourne. He is Group Leader of the Cellular Immunology group at MCRI and his research uses flow cytometry, protein biochemistry and transcriptome analysis to understand the role of immune cells in health and disease. His research is currently supported by an NHMRC RD Wright Fellowship and several NHMRC project grants. Dr Pellicci was recently awarded a CSL Centenary Fellowship, due to commence in January 2019.
Department of Microbiology and Immunology, The University of Melbourne.
2019-23: CSL Centenary Fellowship
2018: Commonwealth Health Ministers Medal, top NHMRC CDF application
2018: NHMRC Research Excellence Award, top NHMRC CDF1 application
2018-21: NHMRC Career Development RD Wright Fellowship (CDF)
2017-19: CR Roper Fellowship
2015: Commendation: Premier's Award for Health and Medical Research
2013: NHMRC Early Career Fellowship (ECF)
2011: Qiagen PhD Achievement award
Dr Pellicci's research focuses on understanding the biology of unconventional T cells in the human immune system. Unconventional T cells make up a large proportion of T cells in humans and rapidly mount potent immune responses upon activation. For this reason, these cells represent potentially important immunotherapeutic targets. He has recently generated novel tetramers to investigate the role of CD1-restricted T cells in tuberculosis, which claims over 1 million lives each year.
The development and homeostasis of MAIT cells.
The role of CD8 co-receptor in MAIT cell activation.
Identification and characterization of CD1d restricted Type-2 NKT cells.
The production of human and macaque CD1 tetramers.
Identification and characterisation of CD1-restricted T cells in healthy versus Mycobacterium tuberculosis (Mtb)-infected or BCG-vaccinated donors.
Investigation of unconventional T cells in macaque models of simian immunodeficiency virus (SIV) and Mtb.
Identification of CD1-restricted lipid antigens.
Structural basis of antigen recognition by CD1-restricted T cells.
Investigation of post-transplant immunity in heart transplant recipients.
*Denotes equal author
Koay HF, Godfrey DI*, Pellicci DG*. “Development of mucosal-associated invariant T cells" Immunol Cell Biol. 2018 Jul;96(6):598-606. Review.
Brennan PJ*, Cheng TY*, Pellicci DG*, Watts GFM, Veerapen N, Young DC, Rossjohn J, Besra GS, Godfrey DI, Brenner MB, Moody DB. “Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface" Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8348-8353
Koay HF, Gherardin NA, Enders A, Loh L, Mackay LK, Almeida CF, Russ BE, Nold-Petry CA, Nold MF, Bedoui S, Chen Z, Corbett AJ, Eckle SBG, Meehan B, d'Udekem Y, Konstantinov IE, Lappas M, Liu L, Goodnow CC, Fairlie DP, Rossjohn J, Chong MM, Kedzierska K, Berzins SP, Belz GT, McCluskey J, Uldrich AP, Godfrey DI* & Pellicci DG* “A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage" Nature Immunology. 2016 Nov;17(11):1300-1311
Le Nours J*, Thirunavukkarasu P*, PellicciD.G*, Gherardin N.A, RossF.J, Lim R.T, BesraG, KeshipeddyS, RichardsonS.K, HowellA.R, GrasS, GodfreyD.I#, Rossjohn J, and Uldrich AP “Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens" Nature Communications. 2016 Feb 15;7:10570.
Birkinshaw RW *, Pellicci DG* , Cheng TY, Keller AN, Sandoval-Romero M, Gras S, de Jong A, Uldrich AP, Moody DB, Godfrey DI, Rossjohn J. “aß T cell antigen receptor recognition of CD1a presenting self lipid ligands" Nature Immunology. 2015 Mar;16(3):258-66.
Pellicci DG*, Uldrich AP*, Le Nours J, Ross F, Chabrol E, Eckle SB, de Boer R, Lim RT, McPherson K, Besra G, Howell AR, Moretta L, McCluskey J, Heemskerk MH, Gras S, Rossjohn J, Godfrey DI. “The molecular bases of d/aß T cell-mediated antigen recognition" J Exp Med. 2014 Dec 15;211(13):2599-615.
Patel O*, Pellicci DG*, Gras S*, Sandoval-Romero ML, Uldrich AP, Mallevaey T, Clarke AJ, Le Nours J, Theodossis A, Cardell SL, Gapin L, Godfrey DI, Rossjohn J. “Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor" Nature Immunology. 2012 Sep;13(9):857-63.
Pellicci DG*, Clarke AJ*, Patel O, Mallevaey T, Beddoe T, Le Nours J, Uldrich AP, McCluskey J, Besra GS, Porcelli SA, Gapin L, Godfrey DI, Rossjohn J. “Recognition of ß-linked self glycolipids mediated by natural killer T cell antigen receptors. Nature Immunology. 2011 Jul 31;12(9):827-33
Patel O*, Pellicci DG*, Uldrich AP, Sullivan LC, Bhati M, McKnight M, Richardson SK, Howell AR, Mallevaey T, Zhang J, Bedel R, Besra GS, Brooks AG, Kjer-Nielsen L, McCluskey J, Porcelli SA, Gapin L, Rossjohn J, Godfrey DI. “Vß2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen" Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19007-12.
- National Health and Medical Research Council (NHMRC)
- Commonwealth Serum Laboratories (CSL)